Pemphigus management guidelines: A life-saving perspective - 07/06/21
Doi : 10.1016/j.jaad.2021.01.105
Saadia Tabassum, MBBS, FCPS Dermatology a, ⁎ 
, Atiya Rahman, MBBS, FCPS Dermatology, MMEd b
, Atiya Rahman, MBBS, FCPS Dermatology, MMEd b a Dermatology Residency Program, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
b Department of Dermatology, Combined Military Hospital (CMH) & CMH Lahore Medical College, Lahore Cantt, Pakistan
∗Correspondence to: Saadia Tabassum, MBBS, FCPS Dermatology, Department of Medicine, Faculty Office Building Second Floor, The Aga Khan University Hospital, Stadium Road, Karachi 74800, PakistanDepartment of MedicineFaculty Office Building Second Floor, The Aga Khan University HospitalStadium RoadKarachi74800Pakistan
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| This is an original unpublished work and is not being submitted for publication elsewhere at the same time. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 85 - N° 1
P. e45-e46 - juillet 2021 Retour au numéro
Article précédent
- Field cancerization: Looking to the future
- Tyler J. Willenbrink, Emily S. Ruiz, Christine M. Cornejo, Chrysalyne D. Schmults, Sarah T. Arron, Anokhi Jambusaria-Pahlajani
- Individual patients’ risk factors impact guidelines for prophylactic agents used in pemphigus patients treated with rituximab
- Dedee F. Murrell, Pascal Joly, Victoria P. Werth
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?